Amarin Corp Plc (AMRN)

[exwannabe]

If it's already at 80%, that's a pickle for sure.

But who says they can not drop it down to 70% or whatever?

From the AMRN POV, that would reduce the value of the company by about 13% (a R-IT fail is death). But the cost reduction in trial time is much more than that.

And if it is the FDA that is the issue, again that was their call that created this so let them cry about a poorly powered trial. They will not halt it.

On cost vs time, that is complicated. It is not just the direct trial costs that play here.